179 related articles for article (PubMed ID: 3490381)
21. Synthesis of high purity 11C labeled palmitic acid for measurement of regional myocardial perfusion and metabolism.
Zielinski F; Robinson G
Int J Nucl Med Biol; 1984; 11(2):121-8. PubMed ID: 6332793
[TBL] [Abstract][Full Text] [Related]
22. Myocardial fatty acid oxidation in patients with impaired glucose tolerance.
Knuuti J; Takala TO; Någren K; Sipilä H; Turpeinen AK; Uusitupa MI; Nuutila P
Diabetologia; 2001 Feb; 44(2):184-7. PubMed ID: 11270674
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and tissue biodistribution of [omega-11C]palmitic acid. A novel PET imaging agent for cardiac fatty acid metabolism.
Buckman BO; VanBrocklin HF; Dence CS; Bergmann SR; Welch MJ; Katzenellenbogen JA
J Med Chem; 1994 Jul; 37(15):2481-5. PubMed ID: 8057294
[TBL] [Abstract][Full Text] [Related]
24. Myocardial perfusion, oxidative metabolism, and free fatty acid uptake in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene: a positron emission tomography study.
Tuunanen H; Kuusisto J; Toikka J; Jääskeläinen P; Marjamäki P; Peuhkurinen K; Viljanen T; Sipola P; Stolen KQ; Hannukainen J; Nuutila P; Laakso M; Knuuti J
J Nucl Cardiol; 2007; 14(3):354-65. PubMed ID: 17556170
[TBL] [Abstract][Full Text] [Related]
25. Assessment of myocardial fatty acid metabolism with positron emission tomography at rest and during dobutamine infusion in patients with coronary artery disease.
Tamaki N; Kawamoto M; Takahashi N; Yonekura Y; Magata Y; Torizuka T; Nohara R; Kambara H; Konishi J
Am Heart J; 1993 Mar; 125(3):702-10. PubMed ID: 8438699
[TBL] [Abstract][Full Text] [Related]
26. Metabolic reserve in normal myocardium assessed by positron emission tomography with C-11 palmitate.
Tamaki N; Kawamoto M; Takahashi N; Yonekura Y; Magata Y; Nohara R; Kambara H; Kawai C; Konishi J
Ann Nucl Med; 1991 Jul; 5(2):53-8. PubMed ID: 1777350
[TBL] [Abstract][Full Text] [Related]
27. Altered regional myocardial metabolism in congestive cardiomyopathy detected by positron tomography.
Geltman EM; Smith JL; Beecher D; Ludbrook PA; Ter-Pogossian MM; Sobel BE
Am J Med; 1983 May; 74(5):773-85. PubMed ID: 6601460
[TBL] [Abstract][Full Text] [Related]
28. Detection and assessment by positron emission tomography of a genetically determined defect in myocardial fatty acid utilization (long-chain acyl-CoA dehydrogenase deficiency).
Kelly DP; Mendelsohn NJ; Sobel BE; Bergmann SR
Am J Cardiol; 1993 Mar; 71(8):738-44. PubMed ID: 8447275
[TBL] [Abstract][Full Text] [Related]
29. Fatty acid uptake is preserved in chronically dysfunctional but viable myocardium.
Mäki MT; Haaparanta MT; Luotolahti MS; Nuutila P; Voipio-Pulkki LM; Bergman JR; Solin OH; Knuuti JM
Am J Physiol; 1997 Nov; 273(5):H2473-80. PubMed ID: 9374787
[TBL] [Abstract][Full Text] [Related]
30. Influence of verapamil on the coronary arteriovenous difference in long chain free fatty acids in hypertrophic cardiomyopathy.
Dubiel JS; Jaśkiewicz J; Zmudka K; Brzostek T; Surdacki A
Eur J Clin Pharmacol; 1992; 42(2):217-8. PubMed ID: 1618255
[TBL] [Abstract][Full Text] [Related]
31. [Correlation of regional wall motion and fatty acid metabolism in coronary artery disease, hypertension, and hypertrophic cardiomyopathy: assessment by dual-isotope SPECT with thallium-201 and iodine-123 beta-methyl fatty acid analogue].
Hase M; Nakata T; Yonekura S; Tsuchihashi K; Kobayashi H; Nagao K; Tanaka S; Kubota M; Tsuda T; Iimura O
Kaku Igaku; 1993 May; 30(5):529-39. PubMed ID: 8336412
[TBL] [Abstract][Full Text] [Related]
32. The Mikamo lecture. Probing the heart's biochemistry with positron emission tomography.
Schelbert HR
Jpn Circ J; 1986 Jan; 50(1):1-29. PubMed ID: 3486300
[No Abstract] [Full Text] [Related]
33. Identification of impaired metabolic reserve by atrial pacing in patients with significant coronary artery stenosis.
Grover-McKay M; Schelbert HR; Schwaiger M; Sochor H; Guzy PM; Krivokapich J; Child JS; Phelps ME
Circulation; 1986 Aug; 74(2):281-92. PubMed ID: 3731419
[TBL] [Abstract][Full Text] [Related]
34. Impairment of BMIPP uptake precedes abnormalities in oxygen and glucose metabolism in hypertrophic cardiomyopathy.
Tadamura E; Kudoh T; Hattori N; Inubushi M; Magata Y; Konishi J; Matsumori A; Nohara R; Sasayama S; Yoshibayashi M; Tamaki N
J Nucl Med; 1998 Mar; 39(3):390-6. PubMed ID: 9529280
[TBL] [Abstract][Full Text] [Related]
35. Abnormal myocardial fatty acid metabolism in dilated cardiomyopathy detected by iodine-123 phenylpentadecanoic acid and tomographic imaging.
Ugolini V; Hansen CL; Kulkarni PV; Jansen DE; Akers MS; Corbett JR
Am J Cardiol; 1988 Nov; 62(13):923-8. PubMed ID: 3263035
[TBL] [Abstract][Full Text] [Related]
36. PET contributions to understanding normal and abnormal cardiac perfusion and metabolism.
Schelbert HR
Ann Biomed Eng; 2000 Aug; 28(8):922-9. PubMed ID: 11144676
[TBL] [Abstract][Full Text] [Related]
37. [Myocardial fatty acid metabolic imaging using C-11 labeled palmitate].
Tamaki N; Kawamoto M; Yonekura Y; Magata Y; Konishi J
Nihon Rinsho; 1991 Jan; 49(1):148-54. PubMed ID: 2002594
[No Abstract] [Full Text] [Related]
38. [Studies of cardiac metabolism with 123I-labelled fatty acids and 11C-methylglucose (author's transl)].
Vyska K; Höck A; Freundlieb C; Becker V; Schmid A; Kloster G; Kloster G; Stöcklin G
Nuklearmedizin; 1981 Jun; 20(3):148-55. PubMed ID: 6973145
[TBL] [Abstract][Full Text] [Related]
39. Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans.
Wisneski JA; Gertz EW; Neese RA; Mayr M
J Clin Invest; 1987 Feb; 79(2):359-66. PubMed ID: 3805273
[TBL] [Abstract][Full Text] [Related]
40. Competition between palmitate and ketone bodies as fuels for the heart: study with positron emission tomography.
Vanoverschelde JL; Wijns W; Kolanowski J; Bol A; Decoster PM; Michel C; Cogneau M; Heyndrickx GR; Essamri B; Melin JA
Am J Physiol; 1993 Mar; 264(3 Pt 2):H701-7. PubMed ID: 8456973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
